Johnson and Johnson Innovation
The Johnson and Johnson Innovation program is an initiative that has built six life science focused accelerators around the country. These accelerators, called JLabs (http://jlabs.jnjinnovation.com/), look to give fledgling life science companies a chance by giving them access to office space and wet lab facilities that only large, established companies generally have access to.
Contents
JLabs Locations
http://jlabs.jnjinnovation.com/locations
San Diego
JLabs flagship location
Located on the Torrey Pines mesa at Janssen Research & Development’s La Jolla-based West Coast Research Center, JLABS San Diego provides access to state-of-the-art equipment, facilities and operations management - thereby enabling new companies to focus on their research. Companies are able to save capital funds and eliminate facility construction and set-up costs, therefore, reducing the time to become operational while gaining access to the benefits of a class A corporate R&D facility.
South San Fransisco
The first stand-alone site
JLABS @ South San Francisco opened March 3, 2015 and can accommodate up to 50 independent, emerging companies. This marked the second expansion in the Bay Area market. Like the successful flagship JLABS in San Diego, JLABS @ South San Francisco includes a combination of shared and private lab and office spaces and features value-added solutions including operational support, education and business services.
Toronto
Labs @ Toronto was the first JLABS to open outside the United States. These facilities are home to over 100 early-stage companies advancing pharmaceutical, medical device, consumer and digital health programs. JLABS @ Toronto will be located at MaRS, occupying one floor of the West Tower and is a collaboration among Johnson & Johnson Innovation, The University of Toronto, MaRS Discovery District, Janssen Inc., MaRS Innovation, and the Government of Ontario. Scheduled to open Spring 2016, the 40,000-square foot facility will include cutting-edge, modular and scalable lab space, state-of-the-art equipment, with access to scientific, industry and capital funding experts. The space – which will be licensed to companies by U of T – will also feature JLABS' inaugural device and digital prototype lab that will provide entrepreneurs with access to highly specialized tools and skills building programs to design and develop smart health technologies.
Texas Medical Center
Houston, as one of the top global biotechnology clusters, and home to the Texas Medical Center, the largest medical center in the world, is a flourishing life science hub. The JLABS model here will enable scientists in the region to take their innovation to the next level, furthering Johnson and Johnson’s goal of helping entrepreneurs advance science with the potential to become transformational solutions for patients.
The new JLABS @ TMC incubator will be located within Texas Medical Center's new Innovation Institute, located at 2450 Holcombe Boulevard, Suite J, Houston, TX 77021. The 34,000-square foot JLABS facility will accommodate up to 50 life science startups. JLABS @ TMC offers opportunities to discuss funding, access third-party services, attend educational events and meet with R&D experts from their medical device, consumer healthcare product and Janssen pharmaceutical teams. JLABS @ TMC will also follow the same no-strings attached approach currently in operation at the California and Boston-based JLABS facilities.
JLABS @ TMC is scheduled to open the first quarter of 2016.
California Institute for Quantitative Biosciences
Through a collaboration between Johnson & Johnson Innovation and the California Institute for Quantitative Biosciences (QB3), JLABS expanded into the San Francisco Bay Area. Johnson & Johnson Innovation has a significant footprint within QB3’s 24,000-square foot incubator space located in the Dogpatch neighborhood, at 953 Indiana St. This marks the first geographical expansion of JLABS. JLABS @ QB3 has a similar open-innovation, no-strings-attached approach like all of our JLABS facilities. JLABS @ QB3 houses innovators who are developing promising solutions to address important unmet medical and consumer needs. Companies have access to QB3’s resources, which include legal and business advisors, assistance in grant writing for federal Small Business Innovation Research funds, and access to high-end equipment and technology in University of California, San Francisco facilities.
LabCentral
The first east coast establishment of JLabs in the Kendall Square biotech hub in Cambridge, Massachusetts, JLABS @ LabCentral will operate with the same open-innovation, no-strings attached approach as it does at all other JLABS locations. As a Founding Sponsor of LabCentral, Johnson & Johnson Innovation selects high-potential innovators for the shared-laboratory space who are focused on promising science that addresses important unmet medical needs. LabCentral is a nonprofit organization, designed to be a “one-stop-shop,” offering premier, fully equipped laboratory space, plus the infrastructure and support that emerging life sciences companies need to transition from a science/technology-focus to a successful commercial-stage enterprise. As part of this agreement, Johnson & Johnson Innovation also has an on-site office to facilitate collaboration with other start-ups located at LabCentral.
